Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Bruce L. Davidson, MD MPH, Philip S. Wells, MD FRCPC, MSc, Martin H. Prins, MD PhD, Jan Beyer-Westendorf, MD, Anthonie WA. Lensing, MD PhD, Lloyd Haskell, MD, Bennett Levitan, MD PhD, François Laliberté, Veronica Ashton, MPH, Yongling Xiao, PhD, Dominique Lejeune, Concetta Crivera, Patrick Lefebvre, MA, Qi Zhao, MPH, Zhong Yuan, MD PhD, Jeff Schein, Paolo Prandoni, MD PhD

Blood (2017) 130 (Supplement 1): 218.

https://doi.org/10.1182/blood.V130.Suppl_1.218.218

Published: 2017

Journal Articles

Evidence-Based Diagnosis of Venous Thromboembolism: A Systematic Review

Ryma Ihaddadene, BHSc, MSc, Melissa Anne Forgie, MD FRCPC, MSc, BA, Philip S. Wells, MD FRCPC, MSc

Blood (2017) 130 (Supplement 1): 2082.

https://doi.org/10.1182/blood.V130.Suppl_1.2082.2082

Published: 2017

Journal Articles

Reduced Costs and Length-of-Stay Associated with Rivaroxaban As Compared to Parenteral Bridging and Warfarin in Pulmonary Embolism Patients Managed in Observation Status

Christine G Kohn, PharmD, Erin R Weeda, PharmD, W Frank Peacock, MD FACEP, Gregory J Fermann, MD, Christopher W. Baugh, MD MBA, Philip S Wells, MD FRCPC, MSc, Veronica Ashton, MPH, Concetta Crivera, PharmD, MPH, Peter Wildgoose, PhD, Jeff Schein, DrPH, MPH, Craig I Coleman, PharmD

Blood (2016) 128 (22): 2337.

https://doi.org/10.1182/blood.V128.22.2337.2337

Published: 2016

Journal Articles

Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study

Lori Ann Linkins, MD MSc, FRCPC, Theodore E. Warkentin, MD, Menaka Pai, MD MSc, FRCP(C), Sudeep Shivakumar, MD, Rizwan Manji, MD PhD MBA, Philip S Wells, MD FRCPC, MSc, Cynthia M Wu, MD FRCPC, Ishac Nazi, PhD, Mark A. Crowther, MD MSc, FRCPC

Blood (2015) 126 (23): 3468.

https://doi.org/10.1182/blood.V126.23.3468.3468

Published: 2015

Journal Articles

A Randomized, Controlled Two-Center Pilot Trial of a 6-Month Exercise Training Program to Treat the Post-Thrombotic Syndrome: The EXPO Pilot Trial.

Susan Kahn, MD, MSc, Ian Shrier, MD, PhD, Stan Shapiro, PhD, Adrielle H Houweling, Andrew Hirsch, MD, Robert Reid, PhD, MBA, Clive Kearon, MB, PhD, Marc Rodger, MD, MSc, Michael J. Kovacs, MD, FRCPC, David Anderson, MD, MSc, Philip S Wells, MD, FRCPC, MSc

Blood (2009) 114 (22): 3984.

https://doi.org/10.1182/blood.V114.22.3984.3984

Published: 2009

Journal Articles

A Systematic Review and Meta-Analysis of Proportions of Thrombosis and Bleeding in Patients Receiving Venous Thromboembolism (VTE) Prophylaxis After Orthopedic Surgery (OS). An Update.

Alejandro Lazo-Langner, MD, MSc, Jeff Hawell, BSc, Michael J. Kovacs, MD, FRCPC, Philip S Wells, MD, FRCPC, MSc, Dimitrios Scarvelis, MD, CM, FRCPC, Melissa Anne Forgie, MD, FRCP(C), Marc Rodger, MD, MSc

Blood (2009) 114 (22): 3125.

https://doi.org/10.1182/blood.V114.22.3125.3125

Published: 2009

Journal Articles

A Pilot Study of Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombois of the Upper Extremity (UEDVT).

Michael J. Kovacs, MD, FRCPC, Roseann Andreou, MD, FRCPC, Marc Rodger, MD, FRCPC, David R. Anderson, MD, FRCPC, Susan R. Kahn, MD, FRCPC, Joy E. Mangel, MD, FRCPC, Beverly Morrow, RN, Anne Marie Clement, RN, CCRP, Philip S. Wells, MD, FRCPC

Blood (2006) 108 (11): 878.

https://doi.org/10.1182/blood.V108.11.878.878

Published: 2006

NARROW

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Evidence-Based Diagnosis of Venous Thromboembolism: A Systematic Review

Reduced Costs and Length-of-Stay Associated with Rivaroxaban As Compared to Parenteral Bridging and Warfarin in Pulmonary Embolism Patients Managed in Observation Status

Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study

A Randomized, Controlled Two-Center Pilot Trial of a 6-Month Exercise Training Program to Treat the Post-Thrombotic Syndrome: The EXPO Pilot Trial.

A Systematic Review and Meta-Analysis of Proportions of Thrombosis and Bleeding in Patients Receiving Venous Thromboembolism (VTE) Prophylaxis After Orthopedic Surgery (OS). An Update.

A Pilot Study of Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombois of the Upper Extremity (UEDVT).

Email alerts

ASH Publications

American Society of Hematology

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Evidence-Based Diagnosis of Venous Thromboembolism: A Systematic Review

Reduced Costs and Length-of-Stay Associated with Rivaroxaban As Compared to Parenteral Bridging and Warfarin in Pulmonary Embolism Patients Managed in Observation Status

Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study

A Randomized, Controlled Two-Center Pilot Trial of a 6-Month Exercise Training Program to Treat the Post-Thrombotic Syndrome: The EXPO Pilot Trial.

A Systematic Review and Meta-Analysis of Proportions of Thrombosis and Bleeding in Patients Receiving Venous Thromboembolism (VTE) Prophylaxis After Orthopedic Surgery (OS). An Update.

A Pilot Study of Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombois of the Upper Extremity (UEDVT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only